Service Delivery and Patient Outcomes in Ryan White HIV/AIDS Program-Funded and -Nonfunded Health Care Facilities in the United States

Outpatient human immunodeficiency virus (HIV) health care facilities receive funding from the Ryan White HIV/AIDS Program (RWHAP) to provide medical care and essential support services that help patients remain in care and adhere to treatment. Increased access to Medicaid and private insurance for H...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JAMA internal medicine Ročník 175; číslo 10; s. 1650 - 1659
Hlavní autoři: Weiser, John, Beer, Linda, Frazier, Emma L, Patel, Roshni, Dempsey, Antigone, Hauck, Heather, Skarbinski, Jacek
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 01.10.2015
Témata:
ISSN:2168-6114
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Outpatient human immunodeficiency virus (HIV) health care facilities receive funding from the Ryan White HIV/AIDS Program (RWHAP) to provide medical care and essential support services that help patients remain in care and adhere to treatment. Increased access to Medicaid and private insurance for HIV-infected persons may provide coverage for medical care but not all needed support services and may not supplant the need for RWHAP funding. To examine differences between RWHAP-funded and non-RWHAP-funded facilities and in patient outcomes between the 2 systems. The study was conducted from June 1, 2009, to May 31, 2012, using data from the 2009 and 2011 cycles of the Medical Monitoring Project, a national probability sample of 8038 HIV-infected adults receiving medical care at 989 outpatient health care facilities providing HIV medical care. Data were used to compare patient characteristics, service needs, and access to services at RWHAP-funded vs non-RWHAP-funded facilities. Differences in prescribed antiretroviral treatment and viral suppression were assessed. Data analysis was performed between February 2012 and June 2015. Overall, 34.4% of facilities received RWHAP funding and 72.8% of patients received care at RWHAP-funded facilities. With results reported as percentage (95% CI), patients attending RWHAP-funded facilities were more likely to be aged 18 to 29 years (8.5% [7.4%-9.5%] vs 5.0% [3.9%-6.2%]), female (29.2% [27.2%-31.2%] vs 20.1% [17.0%-23.1%]), black (47.5% [41.5%-53.5%] vs 25.8% [20.6%-31.0%]) or Hispanic (22.5% [16.4%-28.6%] vs 12.9% [10.6%-15.2%]), have less than a high school education (26.1% [24.0%-28.3%] vs 10.9% [8.7%-13.1%]), income at or below the poverty level (53.6% [50.3%-56.9%] vs 23.9% [19.7%-28.0%]), and lack health care coverage (25.0% [21.9%-28.1%] vs 6.1% [4.1%-8.0%]). The RWHAP-funded facilities were more likely to provide case management (76.1% [69.9%-82.2%] vs 15.4% [10.4%-20.4%]) as well as mental health (64.0% [57.0%-71.0%] vs 18.0% [14.0%-21.9%]), substance abuse (33.6% [27.0%-40.2%] vs 12.0% [8.0%-16.0%]), and other support services; patients attending RWHAP-funded facilities were more likely to receive these services. After adjusting for patient characteristics, the percentage prescribed ART antiretroviral therapy, reported as adjusted prevalence ratio (95% CI), was similar between RWHAP-funded and non-RWHAP-funded facilities (1.01 [0.99-1.03]), but among poor patients, those attending RWHAP-funded facilities were more likely to be virally suppressed (1.09 [1.02-1.16]). A total of 72.8% of HIV-positive patients received care at RWHAP-funded facilities. Many had multiple social determinants of poor health and used services at RWHAP-funded facilities associated with improved outcomes. Without facilities supported by the RWHAP, these patients may have had reduced access to services elsewhere. Poor patients were more likely to achieve viral suppression if they received care at a RWHAP-funded facility.
AbstractList IMPORTANCEOutpatient human immunodeficiency virus (HIV) health care facilities receive funding from the Ryan White HIV/AIDS Program (RWHAP) to provide medical care and essential support services that help patients remain in care and adhere to treatment. Increased access to Medicaid and private insurance for HIV-infected persons may provide coverage for medical care but not all needed support services and may not supplant the need for RWHAP funding.OBJECTIVETo examine differences between RWHAP-funded and non-RWHAP-funded facilities and in patient outcomes between the 2 systems.DESIGN, SETTING, AND PARTICIPANTSThe study was conducted from June 1, 2009, to May 31, 2012, using data from the 2009 and 2011 cycles of the Medical Monitoring Project, a national probability sample of 8038 HIV-infected adults receiving medical care at 989 outpatient health care facilities providing HIV medical care.MAIN OUTCOMES AND MEASURESData were used to compare patient characteristics, service needs, and access to services at RWHAP-funded vs non-RWHAP-funded facilities. Differences in prescribed antiretroviral treatment and viral suppression were assessed. Data analysis was performed between February 2012 and June 2015.RESULTSOverall, 34.4% of facilities received RWHAP funding and 72.8% of patients received care at RWHAP-funded facilities. With results reported as percentage (95% CI), patients attending RWHAP-funded facilities were more likely to be aged 18 to 29 years (8.5% [7.4%-9.5%] vs 5.0% [3.9%-6.2%]), female (29.2% [27.2%-31.2%] vs 20.1% [17.0%-23.1%]), black (47.5% [41.5%-53.5%] vs 25.8% [20.6%-31.0%]) or Hispanic (22.5% [16.4%-28.6%] vs 12.9% [10.6%-15.2%]), have less than a high school education (26.1% [24.0%-28.3%] vs 10.9% [8.7%-13.1%]), income at or below the poverty level (53.6% [50.3%-56.9%] vs 23.9% [19.7%-28.0%]), and lack health care coverage (25.0% [21.9%-28.1%] vs 6.1% [4.1%-8.0%]). The RWHAP-funded facilities were more likely to provide case management (76.1% [69.9%-82.2%] vs 15.4% [10.4%-20.4%]) as well as mental health (64.0% [57.0%-71.0%] vs 18.0% [14.0%-21.9%]), substance abuse (33.6% [27.0%-40.2%] vs 12.0% [8.0%-16.0%]), and other support services; patients attending RWHAP-funded facilities were more likely to receive these services. After adjusting for patient characteristics, the percentage prescribed ART antiretroviral therapy, reported as adjusted prevalence ratio (95% CI), was similar between RWHAP-funded and non-RWHAP-funded facilities (1.01 [0.99-1.03]), but among poor patients, those attending RWHAP-funded facilities were more likely to be virally suppressed (1.09 [1.02-1.16]).CONCLUSIONS AND RELEVANCEA total of 72.8% of HIV-positive patients received care at RWHAP-funded facilities. Many had multiple social determinants of poor health and used services at RWHAP-funded facilities associated with improved outcomes. Without facilities supported by the RWHAP, these patients may have had reduced access to services elsewhere. Poor patients were more likely to achieve viral suppression if they received care at a RWHAP-funded facility.
Outpatient human immunodeficiency virus (HIV) health care facilities receive funding from the Ryan White HIV/AIDS Program (RWHAP) to provide medical care and essential support services that help patients remain in care and adhere to treatment. Increased access to Medicaid and private insurance for HIV-infected persons may provide coverage for medical care but not all needed support services and may not supplant the need for RWHAP funding. To examine differences between RWHAP-funded and non-RWHAP-funded facilities and in patient outcomes between the 2 systems. The study was conducted from June 1, 2009, to May 31, 2012, using data from the 2009 and 2011 cycles of the Medical Monitoring Project, a national probability sample of 8038 HIV-infected adults receiving medical care at 989 outpatient health care facilities providing HIV medical care. Data were used to compare patient characteristics, service needs, and access to services at RWHAP-funded vs non-RWHAP-funded facilities. Differences in prescribed antiretroviral treatment and viral suppression were assessed. Data analysis was performed between February 2012 and June 2015. Overall, 34.4% of facilities received RWHAP funding and 72.8% of patients received care at RWHAP-funded facilities. With results reported as percentage (95% CI), patients attending RWHAP-funded facilities were more likely to be aged 18 to 29 years (8.5% [7.4%-9.5%] vs 5.0% [3.9%-6.2%]), female (29.2% [27.2%-31.2%] vs 20.1% [17.0%-23.1%]), black (47.5% [41.5%-53.5%] vs 25.8% [20.6%-31.0%]) or Hispanic (22.5% [16.4%-28.6%] vs 12.9% [10.6%-15.2%]), have less than a high school education (26.1% [24.0%-28.3%] vs 10.9% [8.7%-13.1%]), income at or below the poverty level (53.6% [50.3%-56.9%] vs 23.9% [19.7%-28.0%]), and lack health care coverage (25.0% [21.9%-28.1%] vs 6.1% [4.1%-8.0%]). The RWHAP-funded facilities were more likely to provide case management (76.1% [69.9%-82.2%] vs 15.4% [10.4%-20.4%]) as well as mental health (64.0% [57.0%-71.0%] vs 18.0% [14.0%-21.9%]), substance abuse (33.6% [27.0%-40.2%] vs 12.0% [8.0%-16.0%]), and other support services; patients attending RWHAP-funded facilities were more likely to receive these services. After adjusting for patient characteristics, the percentage prescribed ART antiretroviral therapy, reported as adjusted prevalence ratio (95% CI), was similar between RWHAP-funded and non-RWHAP-funded facilities (1.01 [0.99-1.03]), but among poor patients, those attending RWHAP-funded facilities were more likely to be virally suppressed (1.09 [1.02-1.16]). A total of 72.8% of HIV-positive patients received care at RWHAP-funded facilities. Many had multiple social determinants of poor health and used services at RWHAP-funded facilities associated with improved outcomes. Without facilities supported by the RWHAP, these patients may have had reduced access to services elsewhere. Poor patients were more likely to achieve viral suppression if they received care at a RWHAP-funded facility.
Author Frazier, Emma L
Dempsey, Antigone
Skarbinski, Jacek
Hauck, Heather
Beer, Linda
Weiser, John
Patel, Roshni
Author_xml – sequence: 1
  givenname: John
  surname: Weiser
  fullname: Weiser, John
  organization: Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia
– sequence: 2
  givenname: Linda
  surname: Beer
  fullname: Beer, Linda
  organization: Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia
– sequence: 3
  givenname: Emma L
  surname: Frazier
  fullname: Frazier, Emma L
  organization: Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia
– sequence: 4
  givenname: Roshni
  surname: Patel
  fullname: Patel, Roshni
  organization: Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia2Health Information and Technology Systems, ICF International, Atlanta, Georgia
– sequence: 5
  givenname: Antigone
  surname: Dempsey
  fullname: Dempsey, Antigone
  organization: HIV/AIDS Bureau, Health Resources and Services Administration, Rockville, Maryland
– sequence: 6
  givenname: Heather
  surname: Hauck
  fullname: Hauck, Heather
  organization: HIV/AIDS Bureau, Health Resources and Services Administration, Rockville, Maryland
– sequence: 7
  givenname: Jacek
  surname: Skarbinski
  fullname: Skarbinski, Jacek
  organization: Division of Global HIV/AIDS and Tuberculosis, Centers for Disease Control and Prevention, Atlanta, Georgia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26322677$$D View this record in MEDLINE/PubMed
BookMark eNo1kEtOwzAYhC0EogV6BfCSTVq_YjdL1FJaqQJEeSwjJ_5NXSUOOA5SL8C5iaDMZjTSzLeYM3TsGw8IXVEypoTQyU7X2vkIwddgxozQdCxIlh6hIaNymkhKxQCN2nZHek0JEZyfogGTnDGp1BB9byB8uRLwHCr3BWGPtTf4UUcHPuKHLpZNDS12Hj_ttcdvWxcBL1evk5vVfIMfQ_MedJ0sOm_A_E6T-8bbv7gEXcUtnukAeKFLV7me-suKW8AvvkcZvIk6QnuBTqyuWhgd_By9LG6fZ8tk_XC3mt2sEy24jAnPVCEMt4ZIkXFWSGYscDklwgibGWNIyRVAaTJqlFU81VRn6RSKwlqbCsHO0fUf9yM0nx20Ma9dW0JVaQ9N1-ZU0SxTKVG0r14eql3Rf5t_BFfrsM__v2M_BEV1rQ
CitedBy_id crossref_primary_10_1007_s10461_019_02508_6
crossref_primary_10_1097_JNC_0000000000000408
crossref_primary_10_1080_09540121_2018_1545988
crossref_primary_10_1097_JNC_0000000000000249
crossref_primary_10_1521_aeap_2018_30_3_187
crossref_primary_10_2196_56892
crossref_primary_10_1093_cid_ciw442
crossref_primary_10_1007_s10461_016_1345_6
crossref_primary_10_1007_s10461_022_03642_4
crossref_primary_10_1093_cid_ciw280
crossref_primary_10_1097_QAD_0000000000003836
crossref_primary_10_1371_journal_pone_0253444
crossref_primary_10_1097_OLQ_0000000000001680
crossref_primary_10_2196_69842
crossref_primary_10_1097_MEG_0000000000000961
crossref_primary_10_1097_QAI_0000000000001276
crossref_primary_10_1002_cncr_30112
crossref_primary_10_3390_ijerph15112404
crossref_primary_10_1177_00333549221074339
crossref_primary_10_1097_QAI_0000000000002592
crossref_primary_10_1080_09540121_2021_1946001
crossref_primary_10_15585_mmwr_mm7336a1
crossref_primary_10_1080_09540121_2019_1576840
crossref_primary_10_1097_QAI_0000000000003605
crossref_primary_10_1097_QAI_0000000000001702
crossref_primary_10_1089_apc_2017_0125
crossref_primary_10_1093_cid_cix380
crossref_primary_10_1097_QAD_0000000000003565
crossref_primary_10_1097_QAD_0000000000001541
crossref_primary_10_1177_10815589241252592
crossref_primary_10_1080_09540121_2024_2417908
crossref_primary_10_1089_aid_2021_0102
crossref_primary_10_1097_QAI_0000000000001779
crossref_primary_10_1371_journal_pone_0264508
crossref_primary_10_1097_QAD_0000000000000986
crossref_primary_10_1038_srep42637
crossref_primary_10_1080_09540121_2023_2221422
crossref_primary_10_1111_1475_6773_13192
crossref_primary_10_1093_cid_civ708
crossref_primary_10_1097_QAI_0000000000001482
crossref_primary_10_1136_bmjopen_2023_076716
crossref_primary_10_1177_15248399231169924
crossref_primary_10_1257_aer_20220089
crossref_primary_10_1080_09540121_2020_1838428
crossref_primary_10_15585_mmwr_mm6740a2
crossref_primary_10_1089_apc_2022_0065
crossref_primary_10_1080_19419899_2022_2112745
crossref_primary_10_1177_2050312119851006
crossref_primary_10_1097_QAI_0000000000001125
crossref_primary_10_1007_s10461_019_02442_7
crossref_primary_10_1007_s10461_021_03415_5
crossref_primary_10_1001_jamanetworkopen_2019_3822
crossref_primary_10_1093_ofid_ofae284
crossref_primary_10_1089_apc_2020_0202
crossref_primary_10_3390_ijerph17010171
crossref_primary_10_1007_s10461_018_2135_0
crossref_primary_10_7759_cureus_91612
crossref_primary_10_1016_S0140_6736_21_00397_4
crossref_primary_10_2147_HIV_S303791
crossref_primary_10_1016_j_jcpo_2024_100555
crossref_primary_10_1080_09540121_2021_1883512
crossref_primary_10_1097_QAI_0000000000001874
crossref_primary_10_1177_2325957417724204
crossref_primary_10_1007_s40746_019_00155_6
crossref_primary_10_7326_M19_4051
crossref_primary_10_1093_cid_ciw418
crossref_primary_10_1016_j_jacl_2020_11_001
crossref_primary_10_1177_0033354919881438
crossref_primary_10_3390_jof7050369
crossref_primary_10_1016_j_socscimed_2021_114628
crossref_primary_10_1097_JNC_0000000000000314
crossref_primary_10_1177_2325957417729750
crossref_primary_10_2196_52123
crossref_primary_10_2196_15453
crossref_primary_10_1097_QAI_0000000000001987
crossref_primary_10_1002_jia2_25382
crossref_primary_10_1097_QAD_0000000000001068
crossref_primary_10_1097_QAI_0000000000003365
crossref_primary_10_15585_mmwr_mm6537a4
crossref_primary_10_1177_2325957415616491
crossref_primary_10_1016_j_xjep_2022_100514
crossref_primary_10_1097_QAI_0000000000003644
crossref_primary_10_37597_ajphes_2025_31_2_7
crossref_primary_10_1093_ofid_ofy283
crossref_primary_10_1136_jech_2025_223751
crossref_primary_10_1080_09540121_2019_1619660
crossref_primary_10_1080_15381501_2021_1970684
crossref_primary_10_1177_2325957417729754
crossref_primary_10_1097_LGT_0000000000000578
crossref_primary_10_1080_09540121_2022_2121954
crossref_primary_10_1093_ofid_ofy202
crossref_primary_10_1097_JNC_0000000000000224
crossref_primary_10_1097_QAD_0000000000002286
crossref_primary_10_1097_QAI_0000000000002546
crossref_primary_10_1080_09540121_2022_2126960
crossref_primary_10_1093_cid_ciac626
crossref_primary_10_1097_QAI_0000000000002547
crossref_primary_10_1093_cid_ciw834
crossref_primary_10_1097_QAI_0000000000002095
crossref_primary_10_1093_ofid_ofac196
crossref_primary_10_1080_09540121_2020_1738007
crossref_primary_10_1093_cid_ciw278
crossref_primary_10_1371_journal_pone_0234652
crossref_primary_10_1089_apc_2018_0032
crossref_primary_10_1093_cid_ciy571
crossref_primary_10_1093_ofid_ofx003
crossref_primary_10_1007_s10461_025_04865_x
crossref_primary_10_1111_jvh_13241
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1001/jamainternmed.2015.4095
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 2168-6114
EndPage 1659
ExternalDocumentID 26322677
Genre Research Support, U.S. Gov't, P.H.S
Journal Article
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: Intramural CDC HHS
  grantid: CC999999
GroupedDBID 0R~
4.4
53G
AAGZG
AAQQT
AARDX
AAWTL
ABBLC
ABJNI
ABPMR
ACDNT
ACGFS
ADBBV
AENEX
AFCHL
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AMJDE
ANMPU
BRYMA
C45
CGR
CUY
CVF
EBD
EBS
ECM
EIF
EJD
EMOBN
EX3
H13
HF~
NPM
OB2
OBH
OCB
OGEVE
OHH
OVD
PQQKQ
RAJ
SV3
TEORI
WH7
WOW
YYP
~H1
7X8
ID FETCH-LOGICAL-a436t-397b4d3fd064932b62dfe36804d4f9ddd0c37eecd91d7f735a1a958ebbfff5442
IEDL.DBID 7X8
ISICitedReferencesCount 116
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000362594600012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
IngestDate Mon Jul 21 11:05:54 EDT 2025
Mon Jul 21 05:58:51 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a436t-397b4d3fd064932b62dfe36804d4f9ddd0c37eecd91d7f735a1a958ebbfff5442
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2430794/ioi150068.pdf
PMID 26322677
PQID 1719975071
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_1719975071
pubmed_primary_26322677
PublicationCentury 2000
PublicationDate 2015-10-01
PublicationDateYYYYMMDD 2015-10-01
PublicationDate_xml – month: 10
  year: 2015
  text: 2015-10-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle JAMA internal medicine
PublicationTitleAlternate JAMA Intern Med
PublicationYear 2015
References 26322484 - JAMA Intern Med. 2015 Oct;175(10):1660-1. doi: 10.1001/jamainternmed.2015.4724.
References_xml – reference: 26322484 - JAMA Intern Med. 2015 Oct;175(10):1660-1. doi: 10.1001/jamainternmed.2015.4724.
SSID ssj0000800433
Score 2.517674
Snippet Outpatient human immunodeficiency virus (HIV) health care facilities receive funding from the Ryan White HIV/AIDS Program (RWHAP) to provide medical care and...
IMPORTANCEOutpatient human immunodeficiency virus (HIV) health care facilities receive funding from the Ryan White HIV/AIDS Program (RWHAP) to provide medical...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1650
SubjectTerms Acquired Immunodeficiency Syndrome - economics
Acquired Immunodeficiency Syndrome - epidemiology
Acquired Immunodeficiency Syndrome - therapy
Adult
Ambulatory Care Facilities - economics
Ambulatory Care Facilities - statistics & numerical data
Anti-Retroviral Agents - therapeutic use
Assessment of Medication Adherence
Female
Financial Management - methods
Financial Management - organization & administration
HIV Infections - economics
HIV Infections - epidemiology
HIV Infections - therapy
Humans
Male
Managed Care Programs - statistics & numerical data
Middle Aged
Needs Assessment
Patient Outcome Assessment
Program Evaluation
Quality Indicators, Health Care
Social Support
United States - epidemiology
Title Service Delivery and Patient Outcomes in Ryan White HIV/AIDS Program-Funded and -Nonfunded Health Care Facilities in the United States
URI https://www.ncbi.nlm.nih.gov/pubmed/26322677
https://www.proquest.com/docview/1719975071
Volume 175
WOSCitedRecordID wos000362594600012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEA7qinjx_VhfRPBat23Spj3J4lp2D1sXX-xtSTMJFKRd7a6wf8DfbdJ09SQIXgo9JC2ZycyXmS8zCF15rhLaC3OHckH1AUX4ThxJU_CSuhlhXMmA180mWJpG43E8agJuVUOrXNrE2lBDKUyMvOMxQ4kw6OVm-uaYrlEmu9q00FhFLaKhjKF0sXH0HWMxaIgSsqR1NcWG8jrUpn2NIXYF1_qAE_wOL2s3k2z_9wd30FYDMHHXasQuWpHFHtoYNin0ffTZWAfck6-Gk7HAvAA8suVV8f18pr8mK5wX-GHBC1w30MP9wUunO-g94pGlczmJuXsG9VAnLQtlX-2dJmzuNOGEC0O7ze1cGmZiC2-xhbcH6Dm5e7rtO00zBodTEs4cjVsyCkSBxjAa82WhD0qSMHIpUBUDgCsIk1JA7AFTTIvf43EQySxTSgWU-odorSgLeYxwpjIfIOCZno1GBGIuFQNXAhM-xK7bRpfLFZ5oZTcZDF7Icl5Nfta4jY6smCZTW5VjYgrP-yFjJ38YfYo2jewtKe8MtZTe6vIcrYuPWV69X9RapJ_paPgF20TV1g
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Service+Delivery+and+Patient+Outcomes+in+Ryan+White+HIV%2FAIDS+Program-Funded+and+-Nonfunded+Health+Care+Facilities+in+the+United+States&rft.jtitle=JAMA+internal+medicine&rft.au=Weiser%2C+John&rft.au=Beer%2C+Linda&rft.au=Frazier%2C+Emma+L&rft.au=Patel%2C+Roshni&rft.date=2015-10-01&rft.eissn=2168-6114&rft.volume=175&rft.issue=10&rft.spage=1650&rft_id=info:doi/10.1001%2Fjamainternmed.2015.4095&rft_id=info%3Apmid%2F26322677&rft_id=info%3Apmid%2F26322677&rft.externalDocID=26322677